Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.57 - $1.16 $27,473 - $55,911
48,200 New
48,200 $29,000
Q2 2022

Aug 15, 2022

SELL
$12.3 - $27.3 $629,760 - $1.4 Million
-51,200 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$16.6 - $32.3 $542,604 - $1.06 Million
32,687 Added 176.56%
51,200 $132,000
Q4 2021

Feb 14, 2022

BUY
$29.9 - $61.2 $553,538 - $1.13 Million
18,513 New
18,513 $55,000
Q2 2021

Aug 13, 2021

SELL
$44.1 - $84.0 $2.73 Million - $5.19 Million
-61,800 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$47.0 - $155.7 $2.9 Million - $9.62 Million
61,800 New
61,800 $499,000
Q3 2020

Nov 12, 2020

SELL
$4.7 - $8.9 $468,674 - $887,490
-99,718 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$2.6 - $5.7 $259,266 - $568,392
99,718 New
99,718 $51,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $133M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.